Member Info for Merchantbanker

I am really not one to make share price predictions usually, but in the current market the right RNS can take this to £2 in the blink of an eye.

Market makers generally will not know a lot about most stocks, how can they. They will obviously get a feel for where volume is and where opportunity is.
They do have in house researchers though, and as soon as Covid come up they would have been all over this learning everything there is to know. The researchers will be constantly updating the market making desk and if its of high enough interest they will be following it closer themselves. They will know what is expected and will be advised to take a position long or short. Just like for us an instant rerate is the quickest way to make money, its the same for them. They are not driven by making an honest market they are driven by making money, accumulating positions and releasing them for profit.

Or they want it for themselves......

In my experience, interacting with the company can do more harm than good. It starts to make you more emotionally invested because they come across nice and friendly and then you fail to see it for what it is as a financial instrument. And things they say start to be misinterpreted or mis represented and you sugar coat it up, which is likely what happened with the twitter gut this morning. It's not what you know its what you think you know that isn't so.

That doesn't sound like advice from someone that has worked in brokers and exchanges for 20 years.

We've had plenty of news and media coverage. Enough to work out what's going on. The company have no obligation to look after traders positions. This is bigger than Omega Diagnostics.

Hope all ok.... just give Colin King a call tell him you hold stock and ask if you can test a POC kit. And then ask him if news is coming tomorrow! 2 birds one stone

This is how i see it....

For the lab tests they are Mologic, we are manufacturing and will earn from our manufacturing contract. We supply the amount they order. Down to them to sell them. They will be contracted to pay for how many we make.

If the mologic tests are not in demand, well does that not open up more capacity to convert the lab test capacity into greater RTC capacity. It might be more profitable for us to pull the plug on lab tests and convert that capacity.

This is why i think we are in a great position and highly derisked, because we are not dependant on the success of a single product. Even if the UK RTC tests don't get to production, we have manufacturing capacity that will not go unused. Our value is how many million tests can we make a year. Obviously the RTC tests would be preferred because i would think the margin would be better as i would expect us to be selling them direct to distribution, other tests may not be as profitable, but our capacity to manufacture millions of tests will be used one way or another that is certain. If RTC fails either by government order or through manufacturing contracting, because demand will far outway supply, we will make millions of tests one way or another.

There's a reason its never us!! Because the government want to absorb as much of the supply for the UK,. They don't need press coverage to spark orders.

If they wanted these other tests they would have come out and told about orders already.

I am not big on listening to things like this either..... but here are some facts:

ODX have increased lab capacity built in one week under urgency week commencing 20th April, with employees moving in on 27th
Colin King mentioned in interview he was expecting more staff returning to work this week.
Fellow consortium member are recruiting for immediate start roles to mobilise production
Scottish and Welsh Governments have announced commencement of Antibody testing this week
Very positive commentary by Sir John Bell on progress with data last week
This is time critical

Final point to learn on GDR.... it closed around £2 last night. They gapped it up, spiked to £3 this morning, placing RNS was released 8.50 am, They were knowingly shafting people this morning. Learn from the pattern of the market. Separate it from the prospects of the stock.
ODX the market pattern looks comfortable, the prospects look great.

GDR is the one other stock i really like. I think it has a lot of promise. But i didn't buy i went all here instead for COVID.

It's holding up not too bad at the moment.

But as i say, learn from that and Motiv. It doesn't appear to be a risk here, with Government funding, and a company that already have positive cash flows and achieved breakeven, as well as new orders.

2 ways mms can make big profits... accumulate low, then gap up let it rise and sell into it releasing profit

run it up short sell, and cover low, usually after bad news or a discount placing.

Apply to what you see here.

You have to learn from patterns. Markets always repeat the same patterns. The market makers and other institutions make consistent profits because of a consistent model. Learn from it. Compare GDR to NVCY. Learn from Motif. Study the patterns and learn to recognise how they are developing. They will save you a lot of money. Which stock is ODX most closely following... NVCY.

Look at GDR placing at 80p. They have been happy to take it up on no news short selling and will cover from the placing. Lesson to learn there. Much more confidence in them holding the stock in range pre news than running it up on expectation.

Need to understand, if you think a share price will go up and you have money to buy, you want to get the best price, so you are happy to buy cheap all the while you can until the big rerate.

Market makers are no different to us. Except they can lead the market where they want to accumulate and they have much bigger pockets. It's simple as that. They have the same goal as us, buy low sell high, or sell high buy low, but they have the freedom to drive the market. It's all about misdirection to make PIs do exactly what they want you to do to improve their position. If their actions appear to motivate you to sell, it probably means the price will go up, if their actions look to motivate you to buy its likely they are short selling and will cover later.

Look at the spread on stocks. Then see how many market makers on each stock. Then think about the average money made on the volume of trades per day. What they would make trading the spread is pennies compared to what they could make by accumulating stock and then gapping it up 50%+ on news. This is gold to market makers, and believe me they wont allow it to move until they have the position that want. The never lose.

You only have to look at Motif yesterday to see how they work. Happy to take it up all day and short sell, making everyone believe it will keep going up selling higher and higher, increasingly short, knowing they will cover it much cheaper today.

Regarding Roche, this is what the smallest of their machines looks like to run this test. Not something that just happens to be lying around or you can send in the post.

https://diagnostics.roche.com/global/en/products/instruments/cobas-e-411.html

cant buy

it’s dropping probably Because of o&g sales. They should be out this week

Scotland start rolling out antibody testing tomorrow

Totally Piper the value here is in manufacturing not design. Variable cost v selling price.
A design is worthless if you can’t make and sell it.
Design will be shared between consortium members.
Millions of units even at small margin is highly valuable.
The risk mitigation here is just that. Our value is in manufacturing capacity. So if worse case scenario the RTC can’t achieve the required test, out capacity will be used by whoever can.
UK is far behind in diagnostics. This will be the making of not only Omega but other small specialists too.

£385k even?